Zhittya Genesis Medicine

Heart Disease, Stroke, Diabetes, Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, And More: CAN Therapeutic ANGIOGENESIS TREAT THEse Disorders?

Changing the World

Heart Disease. Strokes. Diabetes. Humanity has endured these diseases for hundreds of years, claiming millions of lives, and even more livelihoods. No longer. Zhittya Genesis Medicine's drug development has led them to a possible treatment for those diseases and more: growing new blood vessels in the human body, a process referred to as "angiogenesis". FGF-1 is a potent growth factor with just that ability. By growing new blood vessels in the human body, Zhittya believes that FGF-1 could reverse the root causes of those diseases. To establish proper blood flow in any part of the body is essential for that tissue's survival. Recent medical research has pointed to a lack of blood flow to selected parts of the brain as an initiating event in Parkinson's disease, Alzheimer's disease, multiple sclerosis, and more. With our drug, FGF-1, we believe that growing new blood vessels could be a lifesaver for the many who suffer with those diseases.

This shows the drug we are developing, FGF-1, growing new blood vessels in the human heart in a previous US FDA Phase I clinical trial. We believe this same drug could help the millions suffering with other diseases characterized by a lack of blood flow.

Email: questions@zhittyamedicine.com

Phone: 702-802-9855

Zhittya believes that FGF-1 could treat Parkinson's Disease. Our theory is explained in this video.

Zhittya believes that FGF-1 could treat ALS. Our theory is explained in this video.

Zhittya believes that FGF-1 could treat Multiple Sclerosis. Our theory is explained in this video.

Zhittya believes that FGF-1 could treat Multiple System Atrophy. Our theory is explained in this video.